Β-Catenın N-Terminal Bölge Değişikliklerinin Neoplastik Süreçlerdeki Rolünün Araştırılması
View/ Open
Date
2021Author
Uzun, Sarp
xmlui.dri2xhtml.METS-1.0.item-emb
6 ayxmlui.mirage2.itemSummaryView.MetaData
Show full item recordAbstract
Uzun, S, Investigation of The Role of β-catenin N-terminal Domain Alterations in
Neoplastic Processes, Hacettepe University Graduate School of Health Sciences
Tumor Biology and Immunology Program Doctor of Philosophy Thesis, Ankara,
2021. β-catenin is a multifunctional protein and located at the center of Wnt
pathway. Intracellular localization and level of β-catenin are strictly controlled by
special amino acid residues located at its N-terminal domain. These amino acid
residues are encoded by the third exon (exon 3) of CTNNB1 (β-catenin encoding gene)
and the mutations altering this region lead to neoplastic transformation by changing
the amino acid sequence of the N-terminal domain. Our research group has recently
defined an immunohistochemistry-based approach that can detect CTNNB1 exon 3
mutations. The primary purpose of this study is to evaluate the CTNNB1 exon 3
alterations in neoplastic diseases of unknown pathogenesis by using this
immunohistochemistry-based approach. For this purpose, β-catenin N-terminal
domain alterations were evaluated with this method in the cases of sclerosing
angiomatoid nodular transformation (SANT) of the spleen, a rare vascular lesion of
the spleen. As a result of immunohistochemical staining, findings suggesting the
presence of exon 3 mutations were obtained. These findings were confirmed with
polymerase chain reaction and Sanger sequencing. The secondary purpose of this
study is to evaluate the post-translational modifications of the β-catenin N-terminal
domain by using the immunohistochemical staining method that we have described.
For this purpose, the intracellular localization of β-catenin phosphorylated at the
amino acids S33, S37 and T41 (phospho-S33/S37/T41-β-catenin) was investigated
using immunohistochemical and immunofluorescent staining methods, and it was
shown that this protein could accumulate in the nucleus of the colon cancer cells. By
evaluating protein lysates of colorectal cancer patients with Western Blot method, it
was also suggested that low molecular weight β-catenin forms might be formed after
proteolytic cleavage of N-terminal and C-terminal regions of β-catenin.